Trajenta Duo 2.5/500 Tablet

Composition

Metformin (1000mg) + Linagliptin (2.5mg)

Uses of Trajenta Duo 2.5/500 Tablet

Type 2 diabetes mellitus: to improve glycaemic control in adults when diet and exercise alone are not enough; used when appropriate to treat with both linagliptin and metformin.

• •Lowers fasting and post-meal blood sugar
• •Improves insulin sensitivity and reduces glucose production
• •Low risk of hypoglycaemia when used alone
• •Helps achieve HbA1c targets with combination therapy
• •Weight-neutral to modest weight benefit compared with some agents

How it works

Linagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1, GIP), leading to increased insulin release and reduced glucagon in a glucose-dependent manner. Metformin reduces hepatic glucose production and improves peripheral insulin sensitivity, lowering blood glucose.

Directions for use

Oral tablet. Take as prescribed, usually twice daily with meals to reduce stomach upset. Swallow whole with water; do not crush/chew. Maintain diet, exercise, and regular blood sugar monitoring.

Side effects

Common side effects of Trajenta Duo 2.5/500 Tablet may include:

• •Nausea
• •vomiting
• •diarrhoea
• •